JP2005536487A5 - - Google Patents

Download PDF

Info

Publication number
JP2005536487A5
JP2005536487A5 JP2004518958A JP2004518958A JP2005536487A5 JP 2005536487 A5 JP2005536487 A5 JP 2005536487A5 JP 2004518958 A JP2004518958 A JP 2004518958A JP 2004518958 A JP2004518958 A JP 2004518958A JP 2005536487 A5 JP2005536487 A5 JP 2005536487A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
groups
aralkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004518958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536487A (ja
Filing date
Publication date
Priority claimed from GBGB0215526.5A external-priority patent/GB0215526D0/en
Application filed filed Critical
Publication of JP2005536487A publication Critical patent/JP2005536487A/ja
Publication of JP2005536487A5 publication Critical patent/JP2005536487A5/ja
Pending legal-status Critical Current

Links

JP2004518958A 2002-07-05 2003-07-04 ルテニウム抗癌性錯体 Pending JP2005536487A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0215526.5A GB0215526D0 (en) 2002-07-05 2002-07-05 Anticancer compounds
PCT/GB2003/002879 WO2004005304A1 (en) 2002-07-05 2003-07-04 Ruthenium anticancer complexes

Publications (2)

Publication Number Publication Date
JP2005536487A JP2005536487A (ja) 2005-12-02
JP2005536487A5 true JP2005536487A5 (enExample) 2006-04-06

Family

ID=9939861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004518958A Pending JP2005536487A (ja) 2002-07-05 2003-07-04 ルテニウム抗癌性錯体

Country Status (20)

Country Link
US (1) US20060058270A1 (enExample)
EP (1) EP1558620B1 (enExample)
JP (1) JP2005536487A (enExample)
KR (1) KR20050053589A (enExample)
CN (1) CN100362005C (enExample)
AT (1) ATE407937T1 (enExample)
AU (1) AU2003251159B2 (enExample)
BR (1) BR0312470A (enExample)
CA (1) CA2491640A1 (enExample)
DE (1) DE60323529D1 (enExample)
DK (1) DK1558620T3 (enExample)
ES (1) ES2314245T3 (enExample)
GB (1) GB0215526D0 (enExample)
MX (1) MXPA05000314A (enExample)
NO (1) NO20050640L (enExample)
NZ (1) NZ538005A (enExample)
PL (1) PL373049A1 (enExample)
PT (1) PT1558620E (enExample)
WO (1) WO2004005304A1 (enExample)
ZA (1) ZA200500908B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1224192T3 (da) * 1999-10-27 2006-01-02 Univ Court The University Of E Halvsandwich-ruthenium (II)-forbindelser omfattende nitrogenholdige ligander til behandling af cancer
PT1618116E (pt) 2003-04-30 2008-08-18 Univ Edinburgh Complexos de ruténio(ii) para o tratamento de tumores
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
WO2007128158A1 (en) 2006-05-09 2007-11-15 Ecole Polytechnique Federale De Lausanne (Epfl) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
DE102009053392A1 (de) * 2009-11-14 2011-06-22 Umicore AG & Co. KG, 63457 Verfahren zur Herstellung von Ru(0) Olefin-Komplexen
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
CN103360428A (zh) * 2012-04-09 2013-10-23 中国科学院化学研究所 抑制蛋白酪氨酸磷酸酶1b活性的含钌配合物及其制备方法和蛋白酪氨酸磷酸酶1b抑制剂
CN102964385B (zh) * 2012-11-30 2015-02-18 广西师范学院 一种有机金属钌化合物及其制备方法和用途
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same
CZ310511B6 (cs) * 2023-09-18 2025-09-10 Univerzita Palackého v Olomouci Koordinační sloučeniny osmia pro použití pro léčbu plicních nádorových onemocnění

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
EP0916637B1 (en) * 1995-12-06 2005-04-20 Japan Science and Technology Agency Process for preparating optically active compounds
DK1224192T3 (da) * 1999-10-27 2006-01-02 Univ Court The University Of E Halvsandwich-ruthenium (II)-forbindelser omfattende nitrogenholdige ligander til behandling af cancer
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds

Similar Documents

Publication Publication Date Title
JP2005536487A5 (enExample)
JP2007505902A5 (enExample)
JP4923216B2 (ja) 化合物
JP2008511601A5 (enExample)
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
FR2854633A1 (fr) Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
JP2009530306A5 (enExample)
RU2005102592A (ru) Производные индолинфенилсульфамида
HUP0002347A2 (hu) Hidantoin-, oxazol- és pirrolszármazékok alkalmazása gyulladásos betegségek kezelésére alkalmazható gyógyszerkészítmények előállítására
CA2489209A1 (fr) Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
JP2008505157A5 (enExample)
JPWO2022228493A5 (enExample)
DE50304030D1 (de) Verfahren zur Herstellung von 5-Nitrobenzofuranen
JP2013533253A5 (enExample)
BRPI0519443A2 (pt) composto orgÂnicos
JP2008545718A5 (enExample)
RU94030470A (ru) Производные 1-(арилалкиламиноалкил)имидазола, способ их получения, фармацевтическая композиция и способ лечения
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors
JP2004502696A5 (enExample)
JP2004538278A5 (enExample)
JP2008542386A5 (enExample)
JP2005501121A5 (enExample)
JP2007515399A5 (enExample)
WO2015155262A1 (fr) Composes cytotoxiques inhibiteurs de la polymerisation de la tubuline
JP2005526073A5 (enExample)